v3.26.1
Revenue
 6 Months Ended
Jun. 30, 2026
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
The table below provides a disaggregation of revenues by type and customer location for the three and six months ended June 30, 2026 and 2025:

Three Months Ended
June 30,		Six Months Ended
June 30,
(in thousands)2026202520262025
Types of goods and services
Product revenues, net$18,634 $18,085 $38,667 $35,489 
License revenues— — — 5,000 
Royalties614 754 1,432 1,383 
Total revenue $19,248 $18,839 $40,099 $41,872 
Customer Location
U.S.$18,634 $18,085 $38,667 $35,489 
EMEA(1)
614 754 1,432 6,383 
Total revenue $19,248 $18,839 $40,099 $41,872 
(1) Europe, the Middle East and Africa
Product revenues, net
The table below provides a rollforward of the Company’s accruals related to the gross-to-net (“GTN”) sales adjustments for the three and six months ended June 30, 2026:

(in thousands)Discarded Drug RebateOther AdjustmentsTotal
Balance as of March 31, 2026$10,175 $2,374 $12,549 
GTN accruals for current period2,058 4,503 6,561 
Prior period adjustments— (258)(258)
Credits, payments and reclassifications— (4,525)(4,525)
Balance as of June 30, 2026$12,233 $2,094 $14,327 
Balance as of December 31, 2025$7,964 $2,714 $10,678 
GTN accruals for current period4,269 9,485 13,754 
Prior period adjustments— (679)(679)
Credits, payments and reclassifications— (9,426)(9,426)
Balance as of June 30, 2026$12,233 $2,094 $14,327 
The table below provides a rollforward of the Company’s accruals related to the gross-to-net (“GTN”) sales adjustments for the three and six months ended June 30, 2025:

(in thousands)Discarded Drug RebateOther AdjustmentsTotal
Balance as of March 31, 2025$9,672 $2,367 $12,039 
GTN accruals for current period2,020 3,904 5,924 
Prior period adjustments— (241)(241)
Credits, payments and reclassifications— (3,540)(3,540)
Balance as of June 30, 2025$11,692 $2,490 $14,182 
Balance as of December 31, 2024$15,103 $2,386 $17,489 
GTN accruals for current period3,969 8,010 11,979 
Prior period adjustments(200)(573)(773)
Credits, payments and reclassifications(7,180)(7,333)(14,513)
Balance as of June 30, 2025$11,692 $2,490 $14,182 
The table below provides the classification of the accruals related to the GTN sales adjustment included in the Company’s unaudited condensed consolidated balance sheets as of June 30, 2026 and December 31, 2025.

(in thousands)June 30, 2026December 31, 2025
Accounts receivable, net$1,607 $1,658 
Other current and non-current liabilities12,720 9,020 
$14,327 $10,678 
Customers from which we derive more than 10% of our total product revenues for the three and six months ended June 30, 2026 and 2025 are as follows:

Three Months Ended
June 30,		Six Months Ended
June 30,
2026202520262025
AmerisourceBergen Corporation(1)
40 %39 %40 %40 %
McKesson37 %40 %36 %37 %
Cardinal Health23 %21 %24 %23 %
(1) AmerisourceBergen also operates under the name Cencora.